CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU

CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU

Abstract. Evaluation of reactogenicity, safety and immunogenicity of the inactivated subunit influenza vaccine adsorbed monovalent (Pandeflu) on the base of strain A/California/7/2009 (H1N1v) was conducted in 70 volunteers aged 18–60 years immunized by one or two doses. A clinical trial of the vacci...

Full description

Saved in:
Bibliographic Details
Main Authors: M. K. Erofeeva, V. L. Maksakova, I. Y. Nickonorov, M. G. Pozdnyakova, O. S. Kotova, E. A. Okhapkina, V. D. Evgrafov, E. M. Voicehovskaya, A. A. Vasilyeva, M. A. Stukova, D. S. Bushmenkov, A. A. Romanova, O. I. Kiselev
Format: article
Language:RU
Published: Sankt-Peterburg : NIIÈM imeni Pastera 2014
Subjects:
clinical trials
pandemia
influenza
vaccine
pandeflu
Infectious and parasitic diseases
RC109-216
Online Access:https://doaj.org/article/c2a2b5bb3d9c497b9eba6028679e79ee
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c2a2b5bb3d9c497b9eba6028679e79ee

Similar Items